Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 26

Trial Status

Completed6
Terminated4

Role Distribution

Principal Investigator2
Other Roles8
PI Rate20%

Activity Timeline

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

LymphomaMelanoma (Skin)Metastatic Melanoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score24%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Metastatic MelanomaCancer of Kidney

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score12%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Metastatic MelanomaCancer of Kidney

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score12%

Steven A. Rosenberg, MD, PhD

NCI - Surgery Branch

Related
29 trials

Shared therapeutic areas:

Melanoma (Skin)Cancer of Kidney

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score12%

James L Gulley, M.D.

National Cancer Institute (NCI)

Related
18 trials

Shared therapeutic areas:

LymphomaMetastatic Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score12%

Robert J. Motzer, MD

Memorial Sloan Kettering Cancer Center

Related
16 trials

Shared therapeutic areas:

Cancer of KidneyMelanoma (Skin)

Worked with same sponsors:

Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)
Similarity Score12%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Gary Schiller, MD

University of California, Los Angeles

Related
3 trials

Shared therapeutic areas:

Lymphoma
Similarity Score6%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Metastatic Melanoma
Similarity Score6%

Corey J. Langer, MD

Fox Chase Cancer Center

Related
16 trials

Shared therapeutic areas:

Lymphoma

Worked with same sponsors:

Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (10)

Showing 10 of 10 trials

NCT00466921Phase 2StudyChair

Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome

Lymphoma
Completed
NCT00301067Phase 1/2StudyChair

Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic Melanoma

Metastatic Melanoma
Completed
NCT00003615Phase 2StudyChair

Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma

Lymphoma
Completed
NCT00002479Phase 2StudyChair

Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome

Lymphoma
Completed
NCT00004106Phase 2StudyChair

Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome

Lymphoma
Terminated
NCT00005788Phase 2StudyChair

Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary Syndrome

Lymphoma
Terminated
NCT00276835Early Phase 1StudyChair

Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer

Kidney CancerMelanoma (Skin)
Completed
NCT00278369Early Phase 1StudyChair

Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer

Kidney Cancer
Completed
NCT00724061Not ApplicablePrincipalInvestigator

Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL

Lymphoma
Terminated
NCT00727532Not ApplicablePrincipalInvestigator

Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Hereditary Clear Cell Renal Cell CarcinomaKidney Cancer
Terminated

All 10 trials loaded